Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Intercure Ord Shs INCR

InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NDAQ:INCR)

No current opinion is available.

Bullboard Posts (NDAQ:INCR)

InterCure Begins 2022 with Record Breaking First Quarter

Record revenue of $341 million in the first quarter of 2022 Adjusted EBITDA2 increased almost 110% year-over-year to...
Betteryear2 - May 16, 2022

to Acquire Multi-National Medical Cannabis Producer “Better”

Marking the First Major Consolidation in Pharmaceutical Grade Medical Cannabis Market Acquisition is Expected to ...
Betteryear2 - February 16, 2022

Expands Pharmacy Chain in Israel

With addition of four new pharmacies, InterCure’s dedicated chain GIVOL now has 20 ...
Betteryear2 - November 15, 2021

Record Third Quarter Financial Results

Seventh consecutive quarter of high double-digit, sequential revenue growth Annualized revenues run rate of $100 million Adjusted...
Betteryear2 - November 15, 2021

Record Preliminary Third Quarter Revenue of CAD$24 million

Achieved a number of firsts and records including: Seventh consecutive quarter of double-digit revenue growth Seventh consecutive...
Betteryear2 - October 25, 2021

CEO Alex Rabinovitch Purchases Over 420,000 Shares

NEW YORK, TORONTO and HERZLIYA, Israel, Oct. 12, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR)...
Betteryear2 - October 12, 2021